Skip to main content
. Author manuscript; available in PMC: 2016 Apr 21.
Published in final edited form as: Am J Obstet Gynecol. 2015 Aug 12;213(6):844.e1–844.e6. doi: 10.1016/j.ajog.2015.08.014

TABLE 1.

Clinical and demographic characteristics of women randomized to 17-alpha hydroxyprogesterone caproate or placebo

Description Value 17OHP-C
N = 294 (%)
Placebo
N = 149 (%)
P value
No. of previous preterm deliveries Mean (SE) 1.40 (0.04) 1.61 (0.07) .016
>1 Previous preterm delivery >1 83 (28.23) 63 (42.28) .004
≥1 Previous term deliveries ≥1 145 (49.32) 69 (46.31) .615
Gestational age at randomization, wk Mean (SE) 18.9 (0.09) 18.8 (0.12) .581
Maternal age, y Mean (SE) 26.1 (0.31) 26.6 (0.43) .382
Race Black 177 (60.20) 89 (59.73) .862
Caucasian 74 (25.17) 34 (22.82)
Hispanic 38 (12.93) 23 (15.44)
Other/unknown 5 (1.70) 3 (2.01)
Marital status Married/living with partner 149 (50.68) 69 (46.31) .629
Divorced/widowed/separated 29 (9.86) 18 (12.08)
Never married 116 (39.46) 62 (41.61)
Years of school completed Mean (SE) 11.8 (0.13) 12.0 (0.19) .379
Smoked during pregnancy Yes 65 (22.11) 30 (20.13) .713
Drank alcohol during pregnancy Yes 26 (8.84) 10 (6.71) .469

17OHP-C, 17-alpha hydroxyprogesterone caproate.